In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
about
Lupus nephritis: current updateMolecular cloning and characterization of an interferon induced human cDNA with sequence homology to a mammalian peptide chain release factorThe role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft RejectionAge-Associated B Cells: A T-bet-Dependent Effector with Roles in Protective and Pathogenic ImmunityInflammatory cytokines in systemic lupus erythematosusPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusInterferon-inducible gene expression signature in peripheral blood cells of patients with severe lupusConstruction, purification, and characterization of a chimeric TH1 antagonist.Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression.Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.TLRs and IFNs: critical pieces of the autoimmunity puzzleTumour necrosis factor and other cytokines in murine lupus.Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in miceTreating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology.Anticytokine gene therapy of autoimmune diseases.Murine models of systemic lupus erythematosusThe mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus.Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathwayImmunopathology and the gene therapy of lupus.Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc.TLR7, IFNγ, and T-bet: their roles in the development of ABCs in female-biased autoimmunity.The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosusMechanisms of immunological tolerance loss versus erythrocyte self-antigens and autoimmune hemolytic anemia.Use of laser microdissection in the analysis of renal-infiltrating T cells in murine lupusLinks between type I interferons and the genetic basis of disease in mouse lupus.Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.Targeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy.Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but not costimulatory signals.Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.Interferons as pathogenic effectors in autoimmunity.Statins: immunomodulators for autoimmune rheumatic disease?Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupusA model of human cytokine regulation based on transfection of gamma interferon gene fragments directly into isolated peripheral blood T lymphocytes.Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.
P2860
Q22000837-D9156D1D-8393-406E-A241-C1D33BC8D008Q24555707-19F1BA63-C8DD-44F9-B3D7-2F495F0912A0Q24805385-21741FF3-AC77-49BD-B170-54AA9B81B476Q26738329-40EA89D8-BC8B-4A9B-B417-64806D290C9AQ26795654-8354E1BF-E6C3-495F-958F-5F8900E846DFQ26823647-E237E487-8143-409A-940B-154B19485381Q28088753-64F0E045-5565-4894-88D4-5392DD3E1AB5Q28212039-FA946DC6-C854-4036-AE3E-329CB2CF91B2Q33244262-E6EFD9D1-A8AF-48A5-92D1-D2A8D00AEF22Q33329462-7AFDD95D-A4FF-40B8-A791-8CDCE15AEDDBQ33346920-3476C50A-7C9D-4248-BD64-B34EC659CFA5Q33354714-7A4509DE-4288-40ED-AA14-A66A4219D880Q33782338-525BDE03-8176-4CF3-9C4B-6BDAFA9F3265Q33973488-0D7694F8-E464-4A68-81BD-3E1A54CF9C40Q34105647-289023CF-3BE6-4CC7-94CA-A29B5657C49BQ34109682-2277A334-DCEE-41F5-B89B-94C9230E8DA4Q34114826-D030D681-283C-4750-B208-9B0FC60A2B92Q34294364-6F9C0868-C9FC-43ED-AF62-713870FBBD9CQ34358387-76D600DF-F772-4DB6-BC55-128D9DE47F7EQ34451949-9B3172BF-2479-4EDF-A21E-B147D4629309Q34591019-ED4E17C6-0EE7-48D5-8F91-3D773161112EQ34649237-DE184830-AC58-4129-81CF-4F791A6C9E4CQ34837305-43CCAE9A-7429-42F5-96F7-F84B974F1B7FQ34939962-5FA64B63-F49F-4DDA-AD4B-29532E7D4667Q35122166-DB3733A0-28B5-4DBC-8CB8-32D91DD7BA5EQ35126621-DB3651B8-1C80-4374-901F-61608598F7B6Q35235610-673F64D9-4EB2-4513-B9BB-8A6749CE8E4EQ35294438-FAB395BC-5CFB-4401-A749-DCDD21A36FBFQ35561441-B58765AB-88A5-4600-A3FA-849488793F4FQ35631769-0C8FAECE-FBD0-4744-A502-31DE8C9A1CD6Q35675523-B47CBD5A-D129-44DD-A210-6B38EBBEC523Q35675526-0ECBA2F6-7A68-4F20-B168-1C1E4B91E128Q35824498-4F758A06-52DE-4BB1-8402-731B4AE55C6EQ35832151-DEC0A96E-F8EF-42DC-B42A-FF96CE2CA2EFQ35833886-6CC73AFF-888E-4B5F-8B60-86FFF19A36E6Q36079852-84A05C8C-48A9-4DB1-933D-C444D516F3BCQ36088044-720F482D-6BCB-4B47-B168-D60978E9C06CQ36259479-C5CB0BCB-EFAE-4091-B7C2-0193DB457C5AQ36352606-D4396F64-36CE-4EC7-A0BD-A8392C2FF84BQ36361141-681A7C7B-9339-446B-B34D-E17265A0F973
P2860
In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@ast
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@en
type
label
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@ast
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@en
prefLabel
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@ast
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@en
P2093
P2860
P356
P1476
In vivo treatment of (NZB X NZ ...... l antibody to gamma interferon
@en
P2093
H O McDevitt
P H van der Meide
P2860
P304
P356
10.1084/JEM.166.3.798
P407
P577
1987-09-01T00:00:00Z